Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bennett

Showing results (421-430 of 834) with videos related to

Pageof 84
Sort By:
Rheumatology (Oxford, England)|April 23, 2004
Dermatomyositis developing in a Duchenne muscular dystrophy carrierA N Bennett, S R Sangle, G R V Hughes, et al.
Human & Experimental Toxicology|May 1, 1990
Metabolism of aspirin after therapeutic and toxic dosesD K Patel, A Hesse, A Ogunbona, et al.
Obstetrics and Gynecology|May 2, 2015
Assessing White's classification of pregestational diabetes in a contemporary diabetic populationStevie N Bennett, Alan Tita, John Owen, et al.
Trends in Microbiology|May 24, 2014
Reconstructing the evolutionary origins and phylogeography of hantavirusesShannon N Bennett, Se Hun Gu, Hae Ji Kang, et al.
Scandinavian Journal of Gastroenterology|January 1, 1975
Effects of carbenoxolone sodium and of aspirin on gastric mucosal potential difference in normal subjectsP N Bennett, G M Frigo, W M Weerasinghe, et al.
Journal of Molecular Biology|May 15, 1978
RNA polymerase interaction at the promoter--operator region of the tryptophan operon of Escherichia coli and Salmonella typhimuriumK D Brown, G N Bennett, F Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1976
Nucleotide sequence of region preceding trp mRNA initiation site and its role in promoter and operator functionG N Bennett, M E Schweingruber, K D Brown, et al.
Metabolic Engineering|August 10, 2000
Effect of glucose analog supplementation on metabolic flux distribution in anaerobic chemostat cultures of Escherichia coliS J Berríos-Rivera, Y T Yang, G N Bennett, et al.
British Journal of Clinical Pharmacology|March 1, 1996
Caffeine as a metabolic probe: NAT2 phenotypingL J Notarianni, P Dobrocky, G Godlewski, et al.
Environmental Toxicology and Chemistry|October 14, 2003
Mutagenicity of nitroaromatic degradation compoundsRanjit S Padda, Chuanyue Wang, Joseph B Hughes, et al.
Pageof 84

Showing results (421-430 of 834) with videos related to

Sort By:
Pageof 84
Rheumatology (Oxford, England)|April 23, 2004
Dermatomyositis developing in a Duchenne muscular dystrophy carrierA N Bennett, S R Sangle, G R V Hughes, et al.
Human & Experimental Toxicology|May 1, 1990
Metabolism of aspirin after therapeutic and toxic dosesD K Patel, A Hesse, A Ogunbona, et al.
Obstetrics and Gynecology|May 2, 2015
Assessing White's classification of pregestational diabetes in a contemporary diabetic populationStevie N Bennett, Alan Tita, John Owen, et al.
Trends in Microbiology|May 24, 2014
Reconstructing the evolutionary origins and phylogeography of hantavirusesShannon N Bennett, Se Hun Gu, Hae Ji Kang, et al.
Scandinavian Journal of Gastroenterology|January 1, 1975
Effects of carbenoxolone sodium and of aspirin on gastric mucosal potential difference in normal subjectsP N Bennett, G M Frigo, W M Weerasinghe, et al.
Journal of Molecular Biology|May 15, 1978
RNA polymerase interaction at the promoter--operator region of the tryptophan operon of Escherichia coli and Salmonella typhimuriumK D Brown, G N Bennett, F Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1976
Nucleotide sequence of region preceding trp mRNA initiation site and its role in promoter and operator functionG N Bennett, M E Schweingruber, K D Brown, et al.
Metabolic Engineering|August 10, 2000
Effect of glucose analog supplementation on metabolic flux distribution in anaerobic chemostat cultures of Escherichia coliS J Berríos-Rivera, Y T Yang, G N Bennett, et al.
British Journal of Clinical Pharmacology|March 1, 1996
Caffeine as a metabolic probe: NAT2 phenotypingL J Notarianni, P Dobrocky, G Godlewski, et al.
Environmental Toxicology and Chemistry|October 14, 2003
Mutagenicity of nitroaromatic degradation compoundsRanjit S Padda, Chuanyue Wang, Joseph B Hughes, et al.
Pageof 84